As we move into the era of personalized medicine, there has been considerable progress made toward an increasingly sophisticated understanding of chronic rhinosinusitis. Precise understanding of the pathophysiology and natural history of the disease has unlocked a novel range of therapeutic options, both medical and surgical. This literature review aims to appraise some of these developments, including the utility of monoclonal antibodies, office based procedures such as balloon sinuplasty and steroid-eluting stents, and adjuncts to surgery such as image guidance. In reviewing the evidence for these novel interventions we aim to provide an insight to the tools which may become commonplace in the arsenal of the rhinologist of the future.